Ratta, R., Haag, E. K., Abraham, C., Coupez, D., Porte, B., Vano, Y. A., Kamoun, T., Turpin, L., Beuzeboc, P. (2026). Enfortumab vedotin (EV) related cutaneous toxicity to predict metabolic response on fluorodeoxyglucose (FDG)-positron emission tomography (PET) scan in advanced urothelial carcinoma (aUC): A single-center experience.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.736